NeuroVive Pharmaceutical AB publishes 2019 Annual report
NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) today announced that the English version of the Annual report for 2019 is now available on the company’s website, www.neurovive.com.
NeuroVive Pharmaceutical AB publishes 2018 Annual report
Lund, Sweden, 25 March 2019, NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the English version of the Annual report for 2018 is now available on the company's ...
NeuroVive Pharmaceutical AB publishes 2017 Annual report
Lund, Sweden, 26 March, 2018, NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the English version of the Annual report for 2017 is now available on the company's ...
NeuroVive Pharmaceutical AB publishes 2016 Annual report
Lund, Sweden, March 23, 2017 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that the English version of the Annual report for ...
NeuroVive Pharmaceutical publishes 2015 annual report
NeuroVive Pharmaceutical AB (publ) today announced that the English version of the annual report for 2015 is now available on the company's website www.neurovive.com. The annual report can also be acc ...
NeuroVive Pharmaceutical publishes English version of annual report for 2014
NeuroVive Pharmaceutical AB (publ) today announced that the English version of the annual report for 2014 is now available on the company's website www.neurovive.com.The annual report can also be acce ...
NeuroVive Pharmaceutical’s 2013 Annual Report now available
Today, NeuroVive Pharmaceutical AB (publ) announced that the Annual Report for 2013 is available as PDF at www.neurovive.com, and can be read via the link below. The available report is in Swedish. An ...